Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer

被引:0
作者
Xin Qing
Chunlei Yuan
Ke Wang
机构
[1] Boai Hospital of Zhongshan Affiliated to Southern Medical University,Clinical Laboratory
[2] Sichuan University,Department of General Surgery, West China Hospital
来源
Breast Cancer | 2023年 / 30卷
关键词
Breast cancer; Proteomics; Prognostic signature; Tumor-infiltrating immune cells; Treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:424 / 435
页数:11
相关论文
共 172 条
[1]  
Sun YS(2017)Risk factors and preventions of breast cancer Int J Biol Sci 13 1387-1397
[2]  
Zhao Z(2020)Breast cancer: biology, biomarkers, and treatments Int Immunopharmacol 84 9S-16S
[3]  
Yang ZN(2016)Clinical diagnosis and management of breast cancer J Nucl Med 57 111-119
[4]  
Xu F(2017)Molecular classification of breast cancer: what the pathologist needs to know Pathology 49 1578-1589
[5]  
Lu HJ(2022)Identification and characterization of three Siglec15-related immune and prognostic subtypes of breast-invasive cancer Int Immunopharmacol 106 328-1423
[6]  
Zhu ZY(2022)Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis Cancer Gene Ther 29 1416-227
[7]  
Barzaman K(2022)Prognosis and dissection of immunosuppressive microenvironment in breast cancer based on fatty acid metabolism-related signature Front Immunol 13 213-143
[8]  
Karami J(2022)Immunotherapy landscape analyses of necroptosis characteristics for breast cancer patients J Transl Med 20 125-572
[9]  
Zarei Z(2020)Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer Acta Oncol 59 562-55
[10]  
Hosseinzadeh A(2019)Serum CEA levels in 49 different types of cancer and noncancer diseases Prog Mol Biol Transl Sci 162 51-31